Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.
- Status
- COMPLETED
- Phase
- PHASE1
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control
- Status
- TERMINATED
- Phase
- PHASE2
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
- Status
- TERMINATED
- Phase
- PHASE2
Study to Nivolumab Following Preoperative Chemoradiotherapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ipilimumab and Nivolumab in Leptomeningeal Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2